| Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ... Expert review of molecular diagnostics 17 (3), 209-215, 2017 | 179 | 2017 |
| Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups DA MacIntyre, B Jimenez, EJ Lewintre, CR Martín, H Schäfer, ... Leukemia 24 (4), 788-797, 2010 | 157 | 2010 |
| Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer D Ajona, MJ Pajares, L Corrales, JL Perez-Gracia, J Agorreta, MD Lozano, ... Journal of the National Cancer Institute 105 (18), 1385-1393, 2013 | 147 | 2013 |
| Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure ER Perna, SM Macı́n, JPC Canella, PM Alvarenga, NG Rı́os, R Pantich, ... International journal of cardiology 99 (2), 253-261, 2005 | 135 | 2005 |
| Facilitated anion transport induces hyperpolarization of the cell membrane that triggers differentiation and cell death in cancer stem cells V Soto-Cerrato, P Manuel-Manresa, E Hernando, S Calabuig-Farinas, ... Journal of the American Chemical Society 137 (50), 15892-15898, 2015 | 116 | 2015 |
| Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions C Mayo-de-Las-Casas, N Jordana-Ariza, M Garzón-Ibañez, A Balada-Bel, ... Annals of Oncology 28 (9), 2248-2255, 2017 | 110 | 2017 |
| Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win? S Calabuig-Farinas, E Jantus-Lewintre, A Herreros-Pomares, C Camps Translational lung cancer research 5 (5), 466, 2016 | 107 | 2016 |
| Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) C Rolfo, AF Cardona, M Cristofanilli, L Paz-Ares, JJD Mochon, I Duran, ... Critical Reviews in Oncology/Hematology 151, 102978, 2020 | 106 | 2020 |
| Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer R Sirera, RM Bremnes, A Cabrera, E Jantus-Lewintre, E Sanmartín, ... Journal of Thoracic Oncology 6 (2), 286-290, 2011 | 106 | 2011 |
| Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer L Puchades-Carrasco, E Jantus-Lewintre, C Pérez-Rambla, ... Oncotarget 7 (11), 12904, 2016 | 97 | 2016 |
| Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer A Herreros-Pomares, JD de-Maya-Girones, S Calabuig-Fariñas, R Lucas, ... Cell death & disease 10 (9), 660, 2019 | 87 | 2019 |
| Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer J García-Foncillas, J Tabernero, E Élez, E Aranda, M Benavides, ... British journal of cancer 119 (12), 1464-1470, 2018 | 84 | 2018 |
| Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology Platform Lungscape Project I Letovanec, S Finn, P Zygoura, P Smyth, A Soltermann, L Bubendorf, ... Journal of Thoracic Oncology 13 (3), 413-425, 2018 | 77 | 2018 |
| Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC E Jantus-Lewintre, E Sanmartín, R Sirera, A Blasco, JJ Sanchez, M Tarón, ... Lung Cancer 74 (2), 326-331, 2011 | 76 | 2011 |
| Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping J Zugazagoitia, I Ramos, JM Trigo, M Palka, A Gómez-Rueda, ... Annals of Oncology 30 (2), 290-296, 2019 | 70 | 2019 |
| MicroRNAs: promising new antiangiogenic targets in cancer S Gallach, S Calabuig-Fariñas, E Jantus-Lewintre, C Camps BioMed research international 2014 (1), 878450, 2014 | 70 | 2014 |
| The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients C Camps, E Jantus-Lewintre, A Cabrera, A Blasco, E Sanmartín, ... Lung Cancer 72 (3), 365-369, 2011 | 69 | 2011 |
| Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects D Ajona, C Zandueta, L Corrales, H Moreno, MJ Pajares, ... American journal of respiratory and critical care medicine 197 (9), 1164-1176, 2018 | 68 | 2018 |
| High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure ER Perna, SM Macin, JPC Canella, PM Alvarenga, RE Pantich, NG Rios, ... Medical Science Monitor 10 (3), CR90-CR95, 2004 | 60 | 2004 |
| Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies C Palanca-Ballester, A Rodriguez-Casanova, S Torres, ... Cancers 13 (12), 3016, 2021 | 56 | 2021 |
Carlos CampsProfessor Medicine在 gva.es 的电子邮件经过验证
